Browse by author
Lookup NU author(s): Dr Stuart Watson,
Dr Peter GallagherORCiD,
Emeritus Professor Nicol Ferrier,
Professor Allan Young
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
The dexamethasone suppression test (DST), frequently abnormal in mood disorder patients, is considered to measure glucocorticoid receptor-mediated negative feedback. We examined the hypothesis that the, apparently more sensitive, dexamethasone/corticotrophin-releasing-hormone (dex/CRH) test unveils subtle hypothalamic-pituitary-adrenal axis disturbance not detected by the DST in 82 patients with mood disorders and 28 controls. There was a close correlation between the cortisol responses on the two tests (rs=0.73, p<0.0005). However, ROC analysis revealed that the dex/CRH test had better diagnostic performance than the DST (p=0.031). The sensitivity of delta cortisol (from the dex/CRH) was 61.9% and the specificity 71.4%. The sensitivity of 1500 h cortisol (the DST) was 66.6% and the specificity was 47.6%. This suggests that the two tests measure common pathology but that the dex/CRH test has better diagnostic utility. © 2006 Elsevier Ltd. All rights reserved.
Author(s): Watson S, Gallagher P, Smith MS, Ferrier IN, Young AH
Publication type: Article
Publication status: Published
ISSN (print): 0306-4530
ISSN (electronic): 1873-3360
PubMed id: 16701957
Altmetrics provided by Altmetric